NCT06575140 Associative Peripheral Stimulation for Reduction of Motor Impairment During Acute Period of Stroke Recovery
| NCT ID | NCT06575140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ahmed A. Rahim |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2021-12-18 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2021-12-18 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Associative Peripheral Stimulation (APS) is a non-invasive therapy intended for stroke rehabilitation involving transcutaneous electrical muscle stimulation paired with voluntary movement. This pilot study investigates whether APS applied during the acute phase of stroke recovery may reduce impairment and improve function in the affected upper extremity.
Eligibility Criteria
Inclusion Criteria: 1. Confirmed ischemic or hemorrhagic stroke no earlier than 7 days prior to enrollment; 2. Presentation of hemiparesis or paralysis of the upper extremity due to stroke; 3. Ability to comprehend and follow study instructions; 4. Ability to initiate finger extension (≥3°) at least three times per minute; 5. Fugl-Meyer Assessment (Upper Extremity) score of \<47. Exclusion Criteria: 1. Contraindications, intolerance, or high sensitivity to the experimental protocol; 2. History of upper-extremity disability prior to the index stroke; 3. Neurological conditions (other than stroke) affecting motor function; 4. Treatment of spasticity/increased tone in the affected upper extremity (e.g., with Botox injection); 5. Lack of access to a safe and suitable place of discharge for experimental sessions and follow-up visits.
Contact & Investigator
Daniel San Juan Orta, MD
STUDY DIRECTOR
National Institute of Neurology & Neurosurgery
Frequently Asked Questions
Who can join the NCT06575140 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 79 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06575140 currently recruiting?
Yes, NCT06575140 is actively recruiting participants. Contact the research team at ahmed.rahim@alumni.ucsf.edu for enrollment information.
Where is the NCT06575140 trial being conducted?
This trial is being conducted at Mexico City, Mexico, Mexico City, Mexico, Mexico City, Mexico.
Who is sponsoring the NCT06575140 clinical trial?
NCT06575140 is sponsored by Ahmed A. Rahim. The principal investigator is Daniel San Juan Orta, MD at National Institute of Neurology & Neurosurgery. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.